452 related articles for article (PubMed ID: 24631082)
1. Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus.
Morozova OV; Bakhvalova VN; Potapova OF; Grishechkin AE; Isaeva EI; Aldarov KV; Klinov DV; Vorovich MF
Vaccine; 2014 May; 32(25):3101-6. PubMed ID: 24631082
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin.
Chernokhaeva LL; Rogova YV; Vorovitch MF; Romanova LIu; Kozlovskaya LI; Maikova GB; Kholodilov IS; Karganova GG
Vaccine; 2016 Apr; 34(20):2354-61. PubMed ID: 27013433
[TBL] [Abstract][Full Text] [Related]
4. Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes.
Fritz R; Orlinger KK; Hofmeister Y; Janecki K; Traweger A; Perez-Burgos L; Barrett PN; Kreil TR
Vaccine; 2012 Feb; 30(6):1165-9. PubMed ID: 22178103
[TBL] [Abstract][Full Text] [Related]
5. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
Orlinger KK; Hofmeister Y; Fritz R; Holzer GW; Falkner FG; Unger B; Loew-Baselli A; Poellabauer EM; Ehrlich HJ; Barrett PN; Kreil TR
J Infect Dis; 2011 Jun; 203(11):1556-64. PubMed ID: 21592984
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of vaccine Encepur Adult for induction of human neutralizing antibodies against recent Far Eastern subtype strains of tick-borne encephalitis virus.
Leonova GN; Ternovoi VA; Pavlenko EV; Maistrovskaya OS; Protopopova EV; Loktev VB
Vaccine; 2007 Jan; 25(5):895-901. PubMed ID: 17011677
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
Chidumayo NN; Yoshii K; Kariwa H
Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
[TBL] [Abstract][Full Text] [Related]
9. Tick-Borne Encephalitis Virus Diversity in Ixodid Ticks and Small Mammals in South-Western Siberia, Russia.
Bakhvalova VN; Chicherina GS; Potapova OF; Panov VV; Glupov VV; Potapov MA; Seligman SJ; Morozova OV
Vector Borne Zoonotic Dis; 2016 Aug; 16(8):541-9. PubMed ID: 27303915
[TBL] [Abstract][Full Text] [Related]
10. Ability of inactivated vaccines based on far-eastern tick-borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients.
Maikova GB; Chernokhaeva LL; Rogova YV; Kozlovskaya LI; Kholodilov IS; Romanenko VV; Esyunina MS; Ankudinova AA; Kilyachina AS; Vorovitch MF; Karganova GG
J Med Virol; 2019 Feb; 91(2):190-200. PubMed ID: 30204244
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains.
Hayasaka D; Goto A; Yoshii K; Mizutani T; Kariwa H; Takashima I
Vaccine; 2001 Sep; 19(32):4774-9. PubMed ID: 11535329
[TBL] [Abstract][Full Text] [Related]
12. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
[TBL] [Abstract][Full Text] [Related]
13. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice.
Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF
Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
[TBL] [Abstract][Full Text] [Related]
15. Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virus.
Matveev AL; Kozlova IV; Stronin OV; Khlusevich YA; Doroshchenko EK; Baykov IK; Lisak OV; Emelyanova LA; Suntsova OV; Matveeva VA; Savinova JS; Tikunova NV
PLoS One; 2019; 14(4):e0215075. PubMed ID: 30958863
[TBL] [Abstract][Full Text] [Related]
16. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
[TBL] [Abstract][Full Text] [Related]
17. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines.
Ruzek D; Avšič Županc T; Borde J; Chrdle A; Eyer L; Karganova G; Kholodilov I; Knap N; Kozlovskaya L; Matveev A; Miller AD; Osolodkin DI; Överby AK; Tikunova N; Tkachev S; Zajkowska J
Antiviral Res; 2019 Apr; 164():23-51. PubMed ID: 30710567
[TBL] [Abstract][Full Text] [Related]
18. [Changes in the reproduction of tick-borne encephalitis virus in cell cultures].
Morozova OV; Grishechkin AE; Bakhvalova VN; Isaeva EI; Podcherniaeva RIa
Vopr Virusol; 2012; 57(2):40-3. PubMed ID: 22834147
[TBL] [Abstract][Full Text] [Related]
19. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
20. Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines.
Beck Y; Fritz R; Orlinger K; Kiermayr S; Ilk R; Portsmouth D; Pöllabauer EM; Löw-Baselli A; Hessel A; Kölch D; Howard MK; Barrett PN; Kreil TR
J Virol; 2016 Feb; 90(4):1964-72. PubMed ID: 26656681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
